药学学报2024,Vol.59Issue(9) :2443-2453.DOI:10.16438/j.0513-4870.2024-0221

人工智能技术在先导化合物发现与优化中的应用进展

Advances of artificial intelligence technology in the discovery and optimization of lead compounds

李紫玥 丛开源 吴诗琪 朱启华 徐云根 邹毅
药学学报2024,Vol.59Issue(9) :2443-2453.DOI:10.16438/j.0513-4870.2024-0221

人工智能技术在先导化合物发现与优化中的应用进展

Advances of artificial intelligence technology in the discovery and optimization of lead compounds

李紫玥 1丛开源 1吴诗琪 1朱启华 1徐云根 1邹毅1
扫码查看

作者信息

  • 1. 中国药科大学药学院,江苏南京 211198
  • 折叠

摘要

近年来,人工智能(artificial intelligence,AI)技术发展突飞猛进,被广泛应用于医学、药学等多个领域,加速了药物研发的进程.本文聚焦AI在先导化合物发现与优化环节的应用,详细介绍了 AI辅助虚拟筛选以及分子生成方法发现先导化合物,特别是AI驱动药物进入临床试验的应用案例,同时简略阐述AI基本算法模型在定量构效关系(quantitative structure-activity relationship,QSAR)和药物重定位中的应用,为基于AI的药物发现提供参考.

Abstract

In recent years,artificial intelligence(AI)technology has advanced rapidly and has been widely applied in various fields such as medicine and pharmacy,accelerating the drug development process.Focusing on the application of AI in the discovery and optimization of lead compounds,this review provides a detailed introduction to AI-assisted virtual screening and molecular generation methods for discovering lead compounds,while particularly highlighting the cases of AI-drived drugs into clinical trials.Additionally,we briefly outline the application of AI basic algorithm models in quantitative structure-activity relationship(QSAR)and drug repurposing,offering insights for AI-based drug discovery.

关键词

人工智能/药物发现/先导化合物/虚拟筛选/分子生成

Key words

artificial intelligence/drug discovery/lead compound/virtual screening/molecular generation

引用本文复制引用

出版年

2024
药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
段落导航相关论文